Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03547726 · ClinicalTrials.gov registry record · NA

Physical Therapy After Reverse Total Shoulder Arthroplasty

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
100
Enrollment target

NCT03547726: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT03547726 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03547726, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
100 participants
Enrollment target

Study Summary

A common operation for various shoulder conditions is a total shoulder arthroplasty (TSA). In cases with severe rotator cuff tears or other conditions, a variant of the procedure called a reverse total shoulder arthroplasty may be performed. It is unclear whether or not patients require formal physical therapy (as opposed to no physical therapy with recommended avoided movements) after reverse TSA. Orthopaedic surgeons have varying opinions on the postoperative rehabilitation protocol for reverse TSA, with some surgeons not prescribing any physical therapy. The purpose of this study is to randomize patients into two groups: one that sees a physical therapist after their reverse TSA, and one that is provided with actions not to perform and are allowed to self-rehabilitate.

Primary Outcome

Active range of motion in the shoulder joint in forward flexion (measured in degrees)

Interventions

  • OTHER Physical Therapy
  • OTHER Self-Rehab

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-02-27
Est. Completion 2022-01-19
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT03547726 record still lists

NCT03547726 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).

The record links to 0 conditions, and to 2 interventions - of which Physical Therapy is the first listed.

NCT03547726 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03547726 about?

NCT03547726 is a clinical study titled "Physical Therapy After Reverse Total Shoulder Arthroplasty". A common operation for various shoulder conditions is a total shoulder arthroplasty (TSA). In cases with severe rotator cuff tears or other conditions, a variant of the procedure called a reverse total shoulder arthroplasty may be performed. It is unclear whether or not patients require formal physi...

What is the current status of trial NCT03547726?

This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2019-02-27. Estimated completion is 2022-01-19.

What interventions are being tested in trial NCT03547726?

The interventions under investigation include: Physical Therapy (OTHER), Self-Rehab (OTHER).

Who is sponsoring clinical trial NCT03547726?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03547726's enrollment target sits among peer trials

100 840th of 2000 higher than 1,081 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03547726, the US trial registry maintained by the National Library of Medicine. NCT03547726 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.